Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2004 2
2005 6
2006 1
2007 5
2008 2
2009 3
2010 3
2011 3
2012 8
2013 8
2014 4
2015 11
2016 15
2017 13
2018 16
2019 8
2020 11
2021 8
2022 6
Text availability
Article attribute
Article type
Publication date

Search Results

122 results
Results by year
Filters applied: . Clear all
Page 1
Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial.
Gerstein HC, Colhoun HM, Dagenais GR, Diaz R, Lakshmanan M, Pais P, Probstfield J, Riesmeyer JS, Riddle MC, Rydén L, Xavier D, Atisso CM, Dyal L, Hall S, Rao-Melacini P, Wong G, Avezum A, Basile J, Chung N, Conget I, Cushman WC, Franek E, Hancu N, Hanefeld M, Holt S, Jansky P, Keltai M, Lanas F, Leiter LA, Lopez-Jaramillo P, Cardona Munoz EG, Pirags V, Pogosova N, Raubenheimer PJ, Shaw JE, Sheu WH, Temelkova-Kurktschiev T; REWIND Investigators. Gerstein HC, et al. Lancet. 2019 Jul 13;394(10193):121-130. doi: 10.1016/S0140-6736(19)31149-3. Epub 2019 Jun 9. Lancet. 2019. PMID: 31189511 Clinical Trial.
Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial.
Gerstein HC, Colhoun HM, Dagenais GR, Diaz R, Lakshmanan M, Pais P, Probstfield J, Botros FT, Riddle MC, Rydén L, Xavier D, Atisso CM, Dyal L, Hall S, Rao-Melacini P, Wong G, Avezum A, Basile J, Chung N, Conget I, Cushman WC, Franek E, Hancu N, Hanefeld M, Holt S, Jansky P, Keltai M, Lanas F, Leiter LA, Lopez-Jaramillo P, Cardona Munoz EG, Pirags V, Pogosova N, Raubenheimer PJ, Shaw JE, Sheu WH, Temelkova-Kurktschiev T; REWIND Investigators. Gerstein HC, et al. Lancet. 2019 Jul 13;394(10193):131-138. doi: 10.1016/S0140-6736(19)31150-X. Epub 2019 Jun 9. Lancet. 2019. PMID: 31189509 Clinical Trial.
Engineered Tools to Study Intercellular Communication.
Yang BA, Westerhof TM, Sabin K, Merajver SD, Aguilar CA. Yang BA, et al. Among authors: aguilar ca. Adv Sci (Weinh). 2020 Dec 21;8(3):2002825. doi: 10.1002/advs.202002825. eCollection 2021 Feb. Adv Sci (Weinh). 2020. PMID: 33552865 Free PMC article. Review.
Sestrins regulate muscle stem cell metabolic homeostasis.
Yang BA, Castor-Macias J, Fraczek P, Cornett A, Brown LA, Kim M, Brooks SV, Lombaert IMA, Lee JH, Aguilar CA. Yang BA, et al. Among authors: aguilar ca. Stem Cell Reports. 2021 Sep 14;16(9):2078-2088. doi: 10.1016/j.stemcr.2021.07.014. Epub 2021 Aug 12. Stem Cell Reports. 2021. PMID: 34388363 Free PMC article.
Efficacy and safety of dapagliflozin in patients with inadequately controlled type 1 diabetes (DEPICT-1): 24 week results from a multicentre, double-blind, phase 3, randomised controlled trial.
Dandona P, Mathieu C, Phillip M, Hansen L, Griffen SC, Tschöpe D, Thorén F, Xu J, Langkilde AM; DEPICT-1 Investigators. Dandona P, et al. Lancet Diabetes Endocrinol. 2017 Nov;5(11):864-876. doi: 10.1016/S2213-8587(17)30308-X. Epub 2017 Sep 14. Lancet Diabetes Endocrinol. 2017. PMID: 28919061 Clinical Trial.
Benefits and pitfalls of data compression in visual working memory.
Lazartigues L, Lavigne F, Aguilar C, Cowan N, Mathy F. Lazartigues L, et al. Among authors: aguilar c. Atten Percept Psychophys. 2021 Oct;83(7):2843-2864. doi: 10.3758/s13414-021-02333-x. Epub 2021 Jun 15. Atten Percept Psychophys. 2021. PMID: 34131860
122 results